Skip to main content
Article
Multiparametric immune profiling in HPV- oral squamous cell cancer.
JCI Insight
  • Zipei Feng, Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA.
  • Daniel Bethmann, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Portland, Oregon, USA
  • Matthias Kappler
  • Carmen Ballesteros-Merino, Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA.
  • Alexander Eckert
  • R Bryan Bell, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Portland, Oregon, USA
  • Allen Cheng
  • Tuan Bui
  • Rom Leidner, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Walter Urba, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, 97213, USA.
  • Kent Johnson
  • Clifford Hoyt
  • Carlo Bifulco, Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, OR
  • Juergen Bukur
  • Claudia Wickenhauser
  • Barbara Seliger
  • Bernard A Fox, Chiles Research Institute Providence Portland Medical Center
Document Type
Article
Publication Date
7-20-2017
Keywords
  • Immunology,
  • Oncology,
  • genomics
Disciplines
Abstract

Evaluation of T lymphocyte frequency provides prognostic information for patients with oral squamous cell cancer (OSCC). However, the effect of simultaneously evaluating T cell frequency and assessing suppressive elements and defects in antigen-processing machinery (APM) has not been clarified. Simultaneous characterization of CD3+, CD8+, FoxP3+, CD163+, and PD-L1+ cells using multispectral imaging was performed on sections from 119 patients with HPV- OSCC. Expression of β2-microglobulin, MHC class I heavy chain, and large multifunctional peptidase 10 was quantified, and all data were correlated with patient outcome. We found that, consistent with previous reports, high numbers of CD8+ T cells at the invasive margin correlated significantly with prolonged overall survival (OS), while the number of FoxP3+ or PD-L1+ cells did not. Compiling the number of FoxP3+ or PD-L1+ cells within 30 μm of CD8+ T cells identified a significant association with a high number of suppressive elements close to CD8+ T cells and reduced OS. Integrating this information into a cumulative suppression index (CSI) increased correlation with OS. Incorporating tumor expression levels of APM components with CSI further improved prognostic power. This multiparametric immune profiling may be useful for stratifying patients with OSCC for clinical trials.

Clinical Institute
Cancer
Specialty
Oncology
Specialty
Earle A. Chiles Research Institute
Specialty
Pathology & Laboratory Medicine
Citation Information
Zipei Feng, Daniel Bethmann, Matthias Kappler, Carmen Ballesteros-Merino, et al.. "Multiparametric immune profiling in HPV- oral squamous cell cancer." JCI Insight (2017)
Available at: http://works.bepress.com/walter-urba/296/